Syra Health Corp financial data

Symbol
SYRA on OTC
Location
Carmel, IN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 342% % -20%
Debt-to-equity 42% % 27%
Return On Equity -51% % 61%
Return On Assets -36% % 64%
Operating Margin -17% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,339,169 shares 26%
Weighted Average Number of Shares Outstanding, Basic 11,939,169 shares 64%
Weighted Average Number of Shares Outstanding, Diluted 11,939,169 shares 64%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $7,498,669 USD -25%
Revenue from Contract with Customer, Excluding Assessed Tax $7,498,669 USD -3.1%
Research and Development Expense $62,584 USD -98%
Operating Income (Loss) $1,270,331 USD 70%
Nonoperating Income (Expense) $4,171 USD -45%
Net Income (Loss) Attributable to Parent $1,266,160 USD 70%
Earnings Per Share, Basic 0 USD/shares 88%
Earnings Per Share, Diluted 0 USD/shares 88%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,976,545 USD
Accounts Receivable, after Allowance for Credit Loss, Current $926,255 USD
Other Assets, Current $307,791 USD -36%
Assets, Current $3,210,591 USD -21%
Property, Plant and Equipment, Net $9,176 USD -73%
Operating Lease, Right-of-Use Asset $43,450 USD -87%
Assets $3,263,217 USD -26%
Accounts Payable, Current $557,056 USD 11%
Accrued Liabilities, Current $224,692 USD -27%
Liabilities, Current $1,053,829 USD 20%
Operating Lease, Liability, Noncurrent $187,212 USD
Liabilities $1,053,829 USD -3.7%
Retained Earnings (Accumulated Deficit) $9,585,956 USD -15%
Stockholders' Equity Attributable to Parent $2,209,388 USD -34%
Liabilities and Equity $3,263,217 USD -26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $158,231 USD
Net Cash Provided by (Used in) Financing Activities $63,051 USD -108%
Net Cash Provided by (Used in) Investing Activities $5,619 USD 42%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $95,180 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,976,545 USD -27%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,229 USD -21%
Deferred Tax Assets, Valuation Allowance $1,900,457 USD 85%
Deferred Tax Assets, Gross $1,900,457 USD 85%
Operating Lease, Liability $43,450 USD -87%
Depreciation $25,449 USD -62%
Payments to Acquire Property, Plant, and Equipment $5,619 USD -42%
Lessee, Operating Lease, Liability, to be Paid $336,262 USD 423%
Operating Lease, Liability, Current $43,450 USD -60%
Lessee, Operating Lease, Liability, to be Paid, Year Two $134,505 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $134,505 USD 109%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -22%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $37,072 USD 3384%
Lessee, Operating Lease, Liability, to be Paid, Year Three $67,252 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $11,783,405 USD 1.2%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $3,229 USD -21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%